Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP) : a highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas
収録刊行物
-
- Cancer Invest
-
Cancer Invest 21 489-496, 2003